Vulto, Arnold G.
Article History
First Online: 12 October 2019
Compliance with Ethical Standards
:
: No funding relevant to this commentary was received.
: AGV is one of the founders of the Research Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL Fund) and is involved in consulting, advisory work and speaking engagements for a number of companies, i.e. AbbVie, Accord, Amgen, Biogen, EGA, Pfizer/Hospira, Mundipharma, Roche, Novartis, Sandoz, and Boehringer Ingelheim.